Aprepep 125mg Capsule
By Aprepep
Rx
3 Capsule in a Strip

Composition
Aprepitant(125mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
December, 2025

liver
Aprepep 125mg Capsule is considered safe for individuals with liver disease based on the available data. It is suggested that adjusting the dose of Aprepep 125mg Capsule may not be necessary for patients with liver issues. However, it is crucial to consult your doctor before using this medication to ensure its appropriateness for your specific condition.

kidney
Aprepep 125mg Capsule is safe to use for patients with kidney disease, and no dose adjustment is needed.

alcohol
Consult your doctor when consuming alcohol with Aprepep 125mg Capsule.

driving
Aprepep 125mg Capsule can reduce alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Aprepep 125mg Capsule may not be safe to use during pregnancy. Limited studies in humans suggest potential harmful effects on the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor before using.

breastfeeding
Aprepep 125mg Capsule may not be safe to use during breastfeeding as it could pass into breastmilk and harm the baby. It is advisable to consult your doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Phenylmorpholine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | NK1 Antagonists |
₹1069.2
₹1188
10% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025